Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
University of Alabama at Birmingham · with Massachusetts General Hospital · NCT07292584
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 125
- US sites recruiting
- 4
- Study start
- April 20, 2026
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to test if a Digital PrEP Toolkit helps cisgender women learn about and access PrEP in Alabama and Mississippi. PrEP is a medication that prevents HIV infection. The main questions it aims to answer are: Can participants complete the Digital PrEP Toolkit in under 10 minutes? Do participants find the Digital PrEP Toolkit useful and easy to use? Does the Digital PrEP Toolkit increase the number of women who start taking PrEP?
Investigators will work with up to 125 women at 3 HIV and STI clinics in Alabama and Mississippi.
Participants will use the Digital PrEP Toolkit on a tablet at the clinic. They will answer questions about their HIV knowledge before and after using the Toolkit. Participants will then discuss PrEP options with a healthcare staff member and decide if they want to start PrEP. Participants will answer follow-up questions at 3 months. Investigators will also review participants' medical records at 6 months to see if they started PrEP and are still taking it.
Being studied: Interactive Digital PrEP Toolkit
Conditions: HIV Prevention; HIV Risk; Sexual and Reproductive Health
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- HIV-negative
- Cisgender women
- 18 years or older
- English-speaking
- Report sexual activity in the last six months or anticipate sexual activity in the next six months.
Exclusion Criteria
- Younger than 18 years of age
- Do not identify as female and/or were not biologically assigned female at birth
- Living with HIV
- Report no sexual activity in the past six months and no anticipated sexual activity in the next six months
- Unable or unwilling to provide informed consent
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35205
Site contact: Victoria McDonald, MPH · 205-975-5713 · vwmcdona@uab.edu
Five Horizons Health Services
Montgomery, AL 36111
Site contact: Director of Research · 334-386-0855 · bwilliams@fivehorizons.org
Five Horizons Health Services
Tuscaloosa, AL 35401
Site contact: Director of Research and Grant Administration · 334-386-0855 · bwilliams@fivehorizons.org
Five Horizons Health Services
Starkville, MS 39759
Site contact: Director of Research and Grant Administration · 334-386-0855 · bwilliams@fivehorizons.org
Study contacts (from the official record)
- Mirjam-Colette Kempf, PhD, MPH · 205-934-9333 · mkempf@uab.edu
- Victoria McDonald, MPH · vwmcdona@uab.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65